ABSTRACT
The SARS-CoV-2 Variants of Concern tracking via Whole Genome Sequencing represents a pillar of public health measures for the containment of the pandemic. The ability to track down the lineage distribution on a local and global scale leads to a better understanding of immune escape and to adopting interventions to contain novel outbreaks. This scenario poses a challenge for NGS laboratories worldwide that are pressed to have both a faster turnaround time and a high-throughput processing of swabs for sequencing and analysis. In this study, we present an optimization of the Illumina COVID-seq protocol carried out on thousands of SARS-CoV-2 samples at the wet and dry level. We discuss the unique challenges related to processing hundreds of swabs per week such as the tradeoff between ultra-high sensitivity and negative contamination levels, cost efficiency and bioinformatics quality metrics.
ABSTRACT
Currently, several hundreds of Terabytes of COVID-19 single-cell RNA-seq (scRNA-seq) data are available in public repositories. This data refers to multiple tissues, comorbidities, and conditions. We expect this trend to continue, and it is realistic to predict amounts of COVID-19 scRNA-seq data increasing to several Petabytes in the coming years. However, thoughtful analysis of this data requires large-scale computing infrastructures, and software systems optimized for such platforms to generate biological knowledge. This paper presents CellHeap, a portable and robust workflow for scRNA-seq customizable analyses, with quality control throughout the execution steps and deployable on supercomputers. Furthermore, we present the deployment of CellHeap in the Santos Dumont supercomputer for analyzing COVID-19 scRNA-seq datasets, and discuss a case study that processed dozens of Terabytes of COVID-19 scRNA-seq raw data. © 2021, Springer Nature Switzerland AG.